blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3087065

EP3087065 - SYNTHESIS OF UROLITHINS [Right-click to bookmark this link]
Former [2016/44]PROCESS-SCALE SYNTHESIS OF UROLITHINS
[2019/09]
StatusNo opposition filed within time limit
Status updated on  27.11.2020
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  20.12.2019
FormerGrant of patent is intended
Status updated on  03.08.2019
FormerExamination is in progress
Status updated on  24.07.2019
FormerGrant of patent is intended
Status updated on  11.03.2019
FormerExamination is in progress
Status updated on  06.04.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Amazentis SA
EPFL Innovation Park Bâtiment C
1015 Lausanne / CH
[2018/25]
Former [2016/44]For all designated states
Amazentis SA
Parc Scientifique Epfl Pse-c
1024 Ecublens / CH
Inventor(s)01 / RINSCH, Christopher, L.
60 Rue de Lausanne
CH-1110 Morges / CH
02 / MÜLLER, Roland
Schwaneplatz 2
93047 Regensburg / DE
03 / SKRANC, Wolfgang
Oberfeldgasse 23
A-1220 Vienna / AT
 [2016/44]
Representative(s)Abel & Imray LLP
Westpoint Building
James Street West
Bath BA1 2DA / GB
[N/P]
Former [2020/04]Abel & Imray
Westpoint Building
James Street West
Bath BA1 2DA / GB
Former [2016/44]Trueman, Lucy Petra
Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
Application number, filing date14828105.822.12.2014
[2016/44]
WO2014US71824
Priority number, dateUS201361919923P23.12.2013         Original published format: US 201361919923 P
[2016/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015100213
Date:02.07.2015
Language:EN
[2015/26]
Type: A2 Application without search report 
No.:EP3087065
Date:02.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.07.2015 takes the place of the publication of the European patent application.
[2016/44]
Type: B1 Patent specification 
No.:EP3087065
Date:22.01.2020
Language:EN
[2020/04]
Search report(s)International search report - published on:EP17.09.2015
ClassificationIPC:C07D311/80
[2016/44]
CPC:
C07D311/80 (EP,US); A61K31/366 (EP,US); A61K33/34 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SYNTHESE VON UROLITHINEN[2019/09]
English:SYNTHESIS OF UROLITHINS[2019/09]
French:SYNTHESE D'UROLITHINES[2019/09]
Former [2016/44]PROZESSSKALIGE SYNTHESE VON UROLITHINEN
Former [2016/44]PROCESS-SCALE SYNTHESIS OF UROLITHINS
Former [2016/44]SYNTHESE D'UROLITHINES A ECHELLE DE PROCEDE
Entry into regional phase18.07.2016National basic fee paid 
18.07.2016Designation fee(s) paid 
18.07.2016Examination fee paid 
Examination procedure18.07.2016Amendment by applicant (claims and/or description)
18.07.2016Examination requested  [2016/44]
06.04.2018Despatch of a communication from the examining division (Time limit: M04)
27.07.2018Reply to a communication from the examining division
12.03.2019Communication of intention to grant the patent
22.07.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.07.2019Fee for grant paid
22.07.2019Fee for publishing/printing paid
12.08.2019Communication of intention to grant the patent
06.12.2019Receipt of the translation of the claim(s)
Divisional application(s)EP20152975.7  / EP3663287
Opposition(s)23.10.2020No opposition filed within time limit [2020/53]
Fees paidRenewal fee
13.12.2016Renewal fee patent year 03
12.12.2017Renewal fee patent year 04
12.12.2018Renewal fee patent year 05
13.12.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.12.2014
AL22.01.2020
CY22.01.2020
CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
MK22.01.2020
MT22.01.2020
PL22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
[2022/31]
Former [2022/30]HU22.12.2014
AL22.01.2020
CY22.01.2020
CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
MT22.01.2020
PL22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2022/27]HU22.12.2014
CY22.01.2020
CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
MT22.01.2020
PL22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
TR22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2021/40]CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
MC22.01.2020
PL22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2021/13]CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
PL22.01.2020
RO22.01.2020
RS22.01.2020
SI22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/50]CZ22.01.2020
DK22.01.2020
EE22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/49]CZ22.01.2020
DK22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SK22.01.2020
SM22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/48]DK22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RO22.01.2020
RS22.01.2020
SM22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/47]DK22.01.2020
ES22.01.2020
FI22.01.2020
HR22.01.2020
LT22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/40]FI22.01.2020
HR22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
IS22.05.2020
PT14.06.2020
Former [2020/39]FI22.01.2020
HR22.01.2020
LV22.01.2020
RS22.01.2020
BG22.04.2020
NO22.04.2020
GR23.04.2020
PT14.06.2020
Former [2020/38]FI22.01.2020
HR22.01.2020
LV22.01.2020
RS22.01.2020
NO22.04.2020
GR23.04.2020
PT14.06.2020
Former [2020/37]FI22.01.2020
HR22.01.2020
LV22.01.2020
RS22.01.2020
NO22.04.2020
PT14.06.2020
Former [2020/36]FI22.01.2020
RS22.01.2020
NO22.04.2020
PT14.06.2020
Former [2020/35]FI22.01.2020
NO22.04.2020
Cited inInternational search[X]EP2674422  (SANTEN PHARMACEUTICAL CO LTD [JP]) [X] 1-33,62 * claims 1, 12; compounds 1-4, 1-7, 1-8, 1-10, 1-11 *;
 [X]  - MACIEJ KRZESZEWSKI ET AL, "Color-Tunable Fluorescent Dyes Based on Benzo[ c ]coumarin", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, (20130916), vol. 2013, no. 25, doi:10.1002/ejoc.201300374, ISSN 1434-193X, pages 5631 - 5644, XP055174487 [X] 1-33,62 * table 1 *

DOI:   http://dx.doi.org/10.1002/ejoc.201300374
 [X]  - SUN WANYING ET AL, "6H-Benzo[c]chromen-6-one derivatives as selective ER[beta] agon", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20060118), vol. 16, no. 6, doi:10.1016/J.BMCL.2005.12.057, ISSN 0960-894X, pages 1468 - 1472, XP028755073 [X] 1-33,62 * Scheme 1;; table 1 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2005.12.057
 [X]  - JAYA PANDEY ET AL, "Synthesis and biological activities of some new dibenzopyranones and dibenzopyrans: search for potential oestrogen receptor agonists and antagonists", BIOORGANIC & MEDICINAL CHEMISTRY, (20040101), vol. 12, no. 9, doi:10.1016/j.bmc.2004.02.018, ISSN 0968-0896, pages 2239 - 2249, XP055100310 [X] 1-33,62 * Scheme 1 step i *

DOI:   http://dx.doi.org/10.1016/j.bmc.2004.02.018
 [A]  - UDO KRAATZ ET AL, "Zur Synthese von Phenanthridinonen-(6) aus 3.4-disubstituierten Cumarinen und ihre Reaktion mit Methylmagnesiumjodid zu Phenanthridiniumjodiden", CHEMISCHE BERICHTE, (19730101), vol. 106, no. 1, doi:10.1002/cber.19731060110, ISSN 0009-2940, pages 62 - 68, XP055172175 [A] 1-33,62 * Scheme page 63 synthesis of the compounds 6a-6d *

DOI:   http://dx.doi.org/10.1002/cber.19731060110
 [IP]  - KAZUHIRO KUDO ET AL, "Scalable Synthesis of 8-Amino-3-hydroxy-6 H -benzo[ c ]chromen-6-one: Key Intermediate for SEGRA via the Hurtley Reaction", ORGANIC PROCESS RESEARCH & DEVELOPMENT, (20141211), vol. 19, no. 1, doi:10.1021/op500334b, ISSN 1083-6160, pages 309 - 314, XP055174456 [IP] 1-33,62 * Schemes 1 and 2 *

DOI:   http://dx.doi.org/10.1021/op500334b
by applicantUS2011065662
 US2012164243
 US2014018415
    - GIL ET AL., J. AGRIC. FOOD CHEM., (2000), vol. 48, pages 4581 - 4589
    - OKUDA ET AL., CHEM. PHARM. BULL., (1982), vol. 30, pages 4230 - 4233
    - OKUDA ET AL., CHEM. PHARM. BULL., (1982), vol. 30, pages 4234 - 4236
    - "Strategies for the synthesis of ellagitannins", KHANBABAEE, K., Chemistry and Biology of Ellagitannins, WORLD SCIENTIFIC PUBLISHING, (2009), pages 152 - 202
    - J. HASSAN ET AL., "Aryl-Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction", CHEMICAL REVIEWS, (2002), vol. 102, no. 5, pages 1359 - 1470
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.